Cancer Genetics, Inc. is an early-stage diagnostics company developing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to the treatment of cancer. The company’s tests target many cancers, including hematological, urogenital, and HPV-associated cancers. It also provides a range of non-proprietary, oncology-focused tests and laboratory services that offer critical genomic information to healthcare professionals, as well as biopharma and biotech. For more information, visit the company’s website at www.cancergenetics.com.